Structure Therapeutics, Inc. (GPCR)
35.00
-0.10
(-0.28%)
USD |
NASDAQ |
Sep 18, 16:00
35.11
+0.11
(+0.31%)
After-Hours: 20:00
Structure Therapeutics Price : 35.00 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 35.04 | 35.63 | 34.42 | 35.00 | 1.548M |
| Sep 17, 2026 | 36.05 | 36.45 | 35.05 | 35.10 | 1.179M |
| Sep 16, 2026 | 39.19 | 39.19 | 35.42 | 35.50 | 1.649M |
| Sep 15, 2026 | 38.36 | 39.03 | 37.75 | 38.95 | 1.471M |
| Sep 14, 2026 | 38.92 | 39.24 | 37.82 | 38.44 | 1.498M |
| Sep 11, 2026 | 39.82 | 40.27 | 38.10 | 38.66 | 1.276M |
| Sep 10, 2026 | 40.51 | 40.90 | 39.29 | 39.55 | 761486.0 |
| Sep 09, 2026 | 41.23 | 44.94 | 40.49 | 41.23 | 1.562M |
| Sep 08, 2026 | 46.84 | 47.38 | 40.26 | 40.38 | 3.418M |
| Sep 04, 2026 | 47.26 | 48.06 | 46.73 | 47.34 | 281710.0 |
| Sep 03, 2026 | 48.21 | 48.25 | 46.37 | 47.34 | 621487.0 |
| Sep 02, 2026 | 47.76 | 48.64 | 46.07 | 47.80 | 1.065M |
| Sep 01, 2026 | 46.02 | 48.03 | 45.58 | 47.13 | 816627.0 |
| Aug 31, 2026 | 47.08 | 47.38 | 45.10 | 45.91 | 1.395M |
| Aug 28, 2026 | 48.93 | 49.20 | 46.96 | 47.37 | 601773.0 |
| Aug 27, 2026 | 49.61 | 49.81 | 48.50 | 49.22 | 318922.0 |
| Aug 26, 2026 | 49.75 | 50.06 | 48.45 | 49.35 | 937165.0 |
| Aug 25, 2026 | 49.65 | 51.02 | 49.37 | 49.92 | 463890.0 |
| Aug 24, 2026 | 48.61 | 49.33 | 47.62 | 49.01 | 822246.0 |
| Aug 21, 2026 | 50.70 | 51.11 | 49.01 | 49.09 | 592574.0 |
| Aug 20, 2026 | 54.15 | 54.60 | 50.33 | 50.52 | 1.429M |
| Aug 19, 2026 | 54.30 | 55.35 | 52.40 | 54.13 | 710055.0 |
| Aug 18, 2026 | 53.70 | 55.60 | 52.58 | 53.53 | 687395.0 |
| Aug 17, 2026 | 54.00 | 54.66 | 53.00 | 53.76 | 305438.0 |
| Aug 14, 2026 | 54.61 | 54.99 | 52.81 | 54.51 | 555889.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1152.93 |
| Novo Nordisk A/S | 43.24 |
| Pfizer Inc. | 27.66 |
| Johnson & Johnson | 269.99 |
| Merck & Co., Inc. | 146.87 |
Price Related Metrics
| Price to Book Value | 1.840 |
| Earnings Yield | -8.80% |
| Market Cap | 2.493B |